66 related articles for article (PubMed ID: 2837494)
1. Effect of mutations affecting Na+: H+ antiport activity on tumorigenic potential of hamster lung fibroblasts.
Lagarde AE; Franchi AJ; Paris S; Pouysségur JM
J Cell Biochem; 1988 Mar; 36(3):249-60. PubMed ID: 2837494
[TBL] [Abstract][Full Text] [Related]
2. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
[TBL] [Abstract][Full Text] [Related]
3. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
Muschel RJ; Williams JE; Lowy DR; Liotta LA
Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
[TBL] [Abstract][Full Text] [Related]
4. Requirement of the Na+/H+ exchanger for tumor growth.
Rotin D; Steele-Norwood D; Grinstein S; Tannock I
Cancer Res; 1989 Jan; 49(1):205-11. PubMed ID: 2535690
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
6. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
7. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
8. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase C-beta1 mediates alpha1-adrenergic receptor-stimulated activation of the sodium-hydrogen exchanger in Chinese hamster lung fibroblasts (CCL39).
Provost JJ; Olmschenk SM; Metcalf AL; Korpi N; Thronson H; Liu M; Wallert MA
Biochem Cell Biol; 2005 Apr; 83(2):123-32. PubMed ID: 15864321
[TBL] [Abstract][Full Text] [Related]
11. The Na+:H+ antiport in cancer.
Lagarde AE; Pouysségur JM
Cancer Biochem Biophys; 1986 Dec; 9(1):1-14. PubMed ID: 3028604
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome.
Bischoff FZ; Strong LC; Yim SO; Pratt DR; Siciliano MJ; Giovanella BC; Tainsky MA
Oncogene; 1991 Feb; 6(2):183-6. PubMed ID: 2000218
[TBL] [Abstract][Full Text] [Related]
13. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
[TBL] [Abstract][Full Text] [Related]
14. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH.
Pouysségur J; Sardet C; Franchi A; L'Allemain G; Paris S
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4833-7. PubMed ID: 6087349
[TBL] [Abstract][Full Text] [Related]
15. Multistep carcinogenesis of normal human fibroblasts. Human fibroblasts immortalized by repeated treatment with Co-60 gamma rays were transformed into tumorigenic cells with Ha-ras oncogenes.
Namba M; Nishitani K; Fukushima F; Kimoto T
Anticancer Res; 1988; 8(5A):947-58. PubMed ID: 3140712
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
17. Emergence of hamster fibroblast tumors in nude mice--evidence for in vivo selection leading to loss of growth factor requirement.
Pérez-Rodriguez R; Chambard JC; Van Obberghen-Schilling E; Franchi A; Pouysségur J
J Cell Physiol; 1981 Dec; 109(3):387-96. PubMed ID: 7320057
[TBL] [Abstract][Full Text] [Related]
18. In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH.
Chiche J; Le Fur Y; Vilmen C; Frassineti F; Daniel L; Halestrap AP; Cozzone PJ; Pouysségur J; Lutz NW
Int J Cancer; 2012 Apr; 130(7):1511-20. PubMed ID: 21484790
[TBL] [Abstract][Full Text] [Related]
19. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
